Bio-pharma major Biocon on expansion mode.
Biocon is banking on a strong research pipeline. The company's focus on oral insulin will continue.
Biocon stock price
On November 26, 2015, at 14:35 hrs Biocon was quoting at Rs 461.30, up Rs 6.90, or 1.52 percent. The 52-week high of the share was Rs 495.70 and the 52-week low was Rs 396.50.
The company's trailing 12-month (TTM) EPS was at Rs 35.36 per share as per the quarter ended September 2015. The stock's price-to-earnings (P/E) ratio was 13.05. The latest book value of the company is Rs 129.18 per share. At current value, the price-to-book value of the company is 3.57.
Set email alert for
ADS BY GOOGLE
video of the day
Nifty to fall below 7500 if Q3 disappoints; GST key: Kumar